Related Experiment Videos

TGF-beta: a cytokine mediator of glomerulosclerosis and a target for therapeutic intervention

W A Border¹, N A Noble, M Ketteler

¹Division of Nephrology, University of Utah School of Medicine, Salt Lake City, USA.

Kidney International. Supplement

|June 1, 1995

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Management of primary and renal hyperparathyroidism: guidelines from the German Association of Endocrine Surgeons (CAEK).

Langenbeck's archives of surgery·2021

Randomised clinical trial: Lactobacillus GG modulates gut microbiome, metabolome and endotoxemia in patients with cirrhosis.

Alimentary pharmacology & therapeutics·2014

[Calciphylaxis. A call for interdisciplinary cooperation].

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·2011

Cinacalcet treatment of primary hyperparathyroidism.

International journal of endocrinology·2011

Switch of ESA therapy from darbepoetin-alpha to epoetin-beta in hemodialysis patients: a single-center experience.

Clinical nephrology·2008

[Is there a correlation between C-reactive protein and calcification inhibitors with cardiovascular parameters and risk factors in hemodialysis patients?].

Deutsche medizinische Wochenschrift (1946)·2007

See all related articles